Fauci. Slaoui. Hahn. Bancel. Heavy times call for biotech’s heavy hitters.

May 29, 2020
It’s a short Friday newsletter with huge news: Drs. Fauci and Slaoui are confirmed to speak at BIO Digital. Here are around 600 words, or 3 minutes, to close out your week.
BIO

It’s a short Friday newsletter with huge news: Drs. Fauci and Slaoui are confirmed to speak at BIO Digital. Here are around 600 words, or 3 minutes, to close out your week.

Fauci. Slaoui. Hahn. Bancel. Heavy times call for biotech’s heavy hitters.

And we’re bringing these industry leaders—and many, many more—to you LIVE during BIO Digital, which takes place June 8-12, 2020. Here’s the scoop on the latest heavy hitters confirmed to speak during our virtual convention.

We’ve confirmed Dr. Anthony Fauci and Dr. Moncef Slaoui as headline speakers during BIO Digital, our virtual convention taking place June 8-12, 2020 from the comfort of your laptop or mobile device.

The details:

  • Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), will join an intimate fireside chat with BIO’s incoming CEO, Dr. Michelle McMurry-Heath, to discuss the science emerging in this crisis.

  • Dr. Moncef Slaoui, Head of U.S. Operation Warp Speed, will talk about what it will take to develop a COVID-19 vaccine—and deliver billions of doses around the world. He’ll be joined by speakers from the Coalition for Epidemic Preparedness Innovation (CEPI), The GAVI Alliance, Merck, and Moderna. 

They’re part of a three-part plenary on vaccine development sponsored by Johnson & Johnson. The plenary will also feature the Duke Margolis Center for Health Policy, the FDA Center for Biologics Evaluation and Research, Novavax, and BIO’s own Phyllis Arthur. 

It’s 1 of 50 live and interactive sessions to bring you the latest news on COVID-19 vaccines and therapies, emerging science straight from the labs, and the pandemic’s impact on global health systems, investment, and policy. 

Yes, Hahn and Bancel will be there, too. FDA Commissioner Stephen Hahn, Moderna CEO Stéphane Bancel, and Merck Chief Patient Officer and former CDC Director Dr. Julie Gerberding are just a few more of the leaders on the agenda.

But that’s not all! Register for BIO Digital and you’ll also get access to 60 on-demand sessions, 250 company presentations, and virtual One-on-One Partnering in a 24-hour global time zone format. 

Our new CEO previews her discussion with Dr. Fauci: “All of America has come to know what those of us in public health have known for decades: He is an unwavering advocate for patients and is critical for helping the country navigate this unprecedented challenge,” says Dr. Michelle McMurry-Heath in a new video clip. “I will ask him where the science is right now, what are realistic expectations for a vaccine, what are his expectations for our industry, and what policy decisions might influence our success or our failure. It will be an exciting discussion, and I hope you will join us.”

 
Twitter
 
LinkedIn
 
Facebook
 

Learn more about BIO Digital on our blog. 

FOMO is real. Click here to register now.

 

More News: 

Axios: How the U.S. might distribute a coronavirus vaccine
“Many Big Pharma companies are promising they will distribute as many vaccines as they can produce, to everyone.” 

Biopharma Dive: Coronavirus vaccine developers plan to enroll tens of thousands in late-stage tests
AstraZeneca, Johnson & Johnson, and Pfizer are already planning for Phase 3 or late-stage clinical trials.

STAT: Big gene therapy names line up behind experimental COVID-19 vaccine
“AveXis, the gene therapy unit of the drug giant Novartis, has signed up to manufacture supplies of the experimental vaccine for human clinical trials at no cost.” 

 
Twitter
 
LinkedIn
 
Facebook
 
BIOTECHNOLOGY: BEYOND IMAGINATION

Sutro Biopharma: The Next Generation of Cancer Therapeutics

Sutro Biopharma: The Next Generation of Cancer Therapeutics
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
 

A new cancer is diagnosed every 30 seconds.  

Cancer accounts for one in six deaths around the world.

Meet Sutro Biopharma, a clinical stage company developing the next generation of cancer therapeutics—with innovative technology to identify and test molecules in a matter of weeks to identify optimal treatments.

The company’s Antibody Drug Conjugates (ADCs) are powerful, targeted therapies designed to selectively kill cancer cells while minimizing effects on healthy tissue. And they have some amazing things in the pipeline.

Click here to watch and learn more.

 
BIO Beltway Report
GoodDayBIO
 
 

President Trump’s Friday: As Twitter continues to keep an eye on him, he’s holding a roundtable with industry executives at the White House on reopening.

What’s Happening on Capitol Hill: Yesterday, the House “passed legislation in a nearly unanimous vote that would relax restrictions on emergency government-backed loans designed to avoid mass layoffs at small businesses,” reports POLITICO.

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook